FSA Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$236K Buy
309
+12
+4% +$8.93K 0.09% 51
2025
Q2
$232K Hold
297
0.09% 47
2025
Q1
$245K Buy
297
+13
+5% +$10.8K 0.1% 48
2024
Q4
$219K Sell
284
-56
-16% -$46.4K 0.09% 50
2024
Q3
$301K Buy
+340
New +$306K 0.12% 40
2024
Q1
$213K Hold
274
0.09% 49
2023
Q4
$160K Buy
+274
New +$160K 0.08% 57
2021
Q1
Sell
-705
Closed -$119K 152
2020
Q4
$119K Buy
+705
New +$105K 0.06% 78
2020
Q3
Sell
-740
Closed -$121K 214
2020
Q2
$121K Sell
740
-200
-21% -$30.7K 0.08% 74
2020
Q1
$130K Sell
940
-270
-22% -$37.1K 0.11% 66
2019
Q4
$159K Buy
+1,210
New +$140K 0.11% 66

Other funds holding LLY

FSA Wealth Management's LLY Position: Q3 2025 in Review

FSA Wealth Management increased its Eli Lilly (LLY) stake by 4% in Q3 2025, buying an estimated $8.93K and bringing the position to 309 shares worth $236K. The position accounts for 0.09% of the portfolio, ranked #51.

FSA Wealth Management first reported a position in LLY in Q4 2019 and has held it in 11 quarters since. The position peaked at $301K in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • FSA Wealth Management held 309 shares of Eli Lilly worth $236K as of Q3 2025.
  • FSA Wealth Management bought 12 Eli Lilly shares in Q3 2025, an estimated $8.93K.
  • Eli Lilly made up 0.09% of FSA Wealth Management's portfolio in Q3 2025, its #51 holding.
  • FSA Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 11 quarters since.
  • FSA Wealth Management's Eli Lilly position peaked at $301K in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.